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INTRODUCTION:  Polymyalgia  rheumatica  (PMR)  is an  inﬂammatory  syndrome  of unknown  etiology  has
also  been  associated  with  concurrent  malignancy.  Here  we  report  PMR  occurring  de  novo  in  a man
following  successful  robotic  radical  prostatectomy.
PRESENTATION OF  CASE:  A  67-year-old  gentleman  underwent  uneventful  robotic  assisted  radical  prosta-
tectomy  with  complete  excision  of  a T2C Gleason  7 tumour  and  a post-operative  undetectable  PSA. Three
weeks  after  surgery  he  developed  pain  and  weakness  of the  upper  arms  requiring  increasing  doses  of
opioids.  Assessment  identiﬁed  a grossly  elevated  ESR  and CRP consistent  with  a clinical  diagnosis  of  PMR.
Treatment  with  oral  steroids  led  to a  rapid  resolution  of symptoms.
DISCUSSION: There  have  been  reported  cases  of  polymyalgia  rheumatica  occurring  following  surgical
procedures  but  not  with  robotic  prostate  surgery.  It has been  proposed  that  surgical  tissue  injury  can
cause  a release  of  inﬂammatory  markers.  Surgical  stress-related  sympathetic  activation  can  also  stimulate
lymphocyte  dependent  inﬂammatory  reactions  by  modulation  of cytokine  production  and lymphocyte
expressed  adrenergic  receptors.
CONCLUSION: We  present  here  the ﬁrst  reported  case  of  PMR  developing  acutely  after  radical  robotic
prostatectomy.  It  is  possible  that  the  surgical  procedure  in this  case  had  triggered  polymyalgia  rheumatica
possibly  through  activation  of immune-mediated  systemic  inﬂammatory  responses.
gical A© 2012 Sur
. Introduction
Polymyalgia rheumatica is an immune-mediated clinical syn-
rome of unknown etiology. It is characterized by proximal myalgia
f the hip and shoulder girdles with accompanying morning stiff-
ess. A causative relationship with genetic factors, infections,
nd malignancies has been postulated. The disease is character-
zed by the presence of monocyte activation and raised levels of
nterleukin-2 (IL-2) and interleukin-6 (IL-6).1 Dendritic cells also
eem to play a signiﬁcant role in the pathogenesis of polymyalgia
heumatica by triggering lymphocyte immune responses.2 It occurs
n genetically predisposed patient, when an environmental factor,
ossibly a virus, causes monocyte activation which helps deter-
ine the production of cytokines that induce manifestations of the
isease. The disease is more common among northern Europeans3
nd those aged over 50 with median age at diagnosis of 72 years.
t is also more prevalent in females.4 Although non-steroidal anti-
nﬂammatory medications may  control symptoms in patients with
ild disease, most patients with polymyalgia rheumatica require
orticosteroids.
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2. Presentation of case
A 67-year-old gentleman was  referred to the urology depart-
ment with a diagnosis of stage T2C adenocarcinoma of the prostate
with a presenting PSA of 7.2 ng/ml and Gleason 3 + 4 = 7 with
no nodal or metastatic disease. Following MDT  discussion and
proper counselling, he underwent an uneventful robotic assisted
radical prostatectomy. His past medical history included mild
asthma, hypothyroidism, gastro-oesophageal reﬂux, hypercholes-
terolaemia and small abdominal aortic aneurysm which was  under
observation. He also had a left total hip replacement 2 years ago.
Urological history included chronic pelvic pain syndrome, detrusor
overactivity and erectile dysfunction. He normally took seretide,
thryoxine, omperazole, Simvastatin and Viagra. There were no
known allergies and he was  non-smoker.
He had an elective robotic assisted radical prostectomy under
general anaesthesia. The surgery was  uneventful with no unex-
pected intra-operative events. He did not have a blood transfusion
and made an unremarkable recovery and was  discharged on the
ﬁrst postoperative day. He was  given paracetamol, non-steroidal
anti-inﬂammatory drugs, Tramadol, laxatives and low molecular
weight heparin on top of his regular medication. The patient was
routinely reviewed in the clinic 2 weeks following the surgery and
Open access under CC BY-NC-ND license.had a successful removal of his catheter. The patient voided well
with reasonable bladder control and was otherwise well.
Three  weeks later, the patient was seen by his general practi-
tioner with bilateral shoulder pain causing a lack of rest and sleep.
BY-NC-ND license.
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e was treated with opioid analgesia and there was  arrangement
ade to investigate this further. He then presented to a local Dis-
rict General Hospital with urinary retention and was  catheterised.
n the interim the patient’s shoulder pain and muscle stiffness had
rogressed with increasing inability to raise his arms above his head
s well as general malaise and lethargy.
The patient was reviewed in the urology outpatient clinic and a
ecision was made to admit him electively for further management
f his symptoms. On admission, there was a clinical suspicion of
olymyalgia rhuematica and inﬂammatory markers were checked.
he patient had raised inﬂammatory markers with erythrocyte sed-
mentation rate (ESR) of 88 (1-h) and C reactive protein of 242 but
ith normal renal, liver and thyroid function tests. Urine culture
evealed no growth. The patient had a normal rigid cystoscopy and
he urinary symptoms and retention were presumed to be caused
y excessive analgesics consumption. He was then referred and
eviewed by the rheumatology team who concurred with the diag-
osis. He was then commenced on a therapeutic trial of 15 mg
rednisolone daily. His symptoms dramatically improved after 48 h
f  treatment with steroids and he was discharged.
The patient was reviewed in clinic 6 weeks following the com-
encement of treatment with repeat inﬂammatory markers. By
his time all symptoms had completely resolved with an ESR of 5
1-h) and a CRP of 3. The prostate histology came back as organ
onﬁned bilateral and multifocal microacinar type adenocarci-
oma with Gleason 3 + 4 = 7. His follow up PSA at 3 months was
0.02 ng/ml which conﬁrmed good disease control.
.  Discussion
There have been reported associations between malignan-
ies (including prostate cancer5,6) and polymyalgia rheumatica.
n many cases it has been quoted that symptoms of polymyalgia
heumatica usually resolve following effective tumour control. In
his context, polymyalgia rheumatica represent a paraneoplastic
henomenon which means disease occur at a distance from the
rimary tumour or metastases and induced by the malignancy
hrough mediators such as hormones, peptides and antibodies.7
his might well have occurred as a co-incidence and not be related
o the operation or prostate cancer. There have, however previously
een reported cases of polymyalgia rheumatica occurring follow-
ng surgical procedures,8,9 but not with robotic prostate surgery.
he mechanisms for this trigger are unclear. It has been proposed
hat surgical tissue injury can cause a release of inﬂammatory mark-
rs including cytokines and other cellular products, which mobilize
nd activate dendritic cells.10 Surgical stress-related sympathetic
ctivation can also stimulate lymphocyte dependent inﬂammatory
eactions by modulation of cytokine production and lymphocyte
xpressed adrenergic receptors.
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4.  Conclusion
In conclusion, it is possible that the surgical procedure in this
case had triggered polymyalgia rheumatica possibly through acti-
vation of immune-mediated systemic inﬂammatory responses. In
this case, this has happened following robotic radical prostatec-
tomy and to our knowledge is the ﬁrst report of such an incident.
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